Molecular imaging of cancer with positron emission tomography
SS Gambhir - Nature Reviews Cancer, 2002 - nature.com
The imaging of specific molecular targets that are associated with cancer should allow
earlier diagnosis and better management of oncology patients. Positron emission …
earlier diagnosis and better management of oncology patients. Positron emission …
Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines
Background The solitary pulmonary nodule (SPN) is a frequent incidental finding that may
represent primary lung cancer or other malignant or benign lesions. The optimal …
represent primary lung cancer or other malignant or benign lesions. The optimal …
Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers
Tumor genetics guides patient selection for many new therapies, and cell culture studies
have demonstrated that specific mutations can promote metabolic phenotypes. However …
have demonstrated that specific mutations can promote metabolic phenotypes. However …
[PDF][PDF] Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography
R Kubota, S Yamada, K Kubota… - Journal of Nuclear …, 1992 - Soc Nuclear Med
MBq) of [6-3Hjthymidine (3H-Thd, Amersham Japan Ltd., Ja pan) and killed 1 hr later. The
tumor was quickly dissected and prepared for frozen sectioning as reported previously (18) …
tumor was quickly dissected and prepared for frozen sectioning as reported previously (18) …
Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis
MK Gould, CC Maclean, WG Kuschner, CE Rydzak… - Jama, 2001 - jamanetwork.com
ContextFocal pulmonary lesions are commonly encountered in clinical practice, and
positron emission tomography (PET) with the glucose analog 18-fluorodeoxyglucose (FDG) …
positron emission tomography (PET) with the glucose analog 18-fluorodeoxyglucose (FDG) …
Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines
MK Gould, J Fletcher, MD Iannettoni, WR Lynch… - Chest, 2007 - Elsevier
Background Pulmonary nodules are spherical radiographic opacities that measure up to 30
mm in diameter. Nodules are extremely common in clinical practice and challenging to …
mm in diameter. Nodules are extremely common in clinical practice and challenging to …
Radiolabeled amino acids: basic aspects and clinical applications in oncology
PL Jager, W Vaalburg, J Pruim… - Journal of nuclear …, 2001 - Soc Nuclear Med
As the applications of metabolic imaging are expanding, radiolabeled amino acids may gain
increased clinical interest. This review first describes the basic aspects of amino acid …
increased clinical interest. This review first describes the basic aspects of amino acid …
Molecular imaging and its biological applications
ME Phelps - Eur J Nucl Med Mol Imaging, 2004 - Springer
This book is written as both a text and a reference book. It contains numerous images from
the biological sciences and clinical practice, tables, graphs, and fig ures, as well as …
the biological sciences and clinical practice, tables, graphs, and fig ures, as well as …
Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose
P Rigo, P Paulus, BJ Kaschten, R Hustinx… - European journal of …, 1996 - Springer
Positron emission tomography (PET) is now primarily used in oncological indication owing
to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing …
to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing …
PET imaging in oncology
R Bar-Shalom, AY Valdivia, MD Blaufox - Seminars in nuclear medicine, 2000 - Elsevier
The role of positron emission tomography (PET) during the past decade has evolved rapidly
from a pure research tool to a methodology of enormous clinical potential. Perhaps the most …
from a pure research tool to a methodology of enormous clinical potential. Perhaps the most …